Annual SGA
$269.75 M
-$14.05 M-4.95%
December 31, 2023
Summary
- As of February 8, 2025, ORGO annual SGA is $269.75 million, with the most recent change of -$14.05 million (-4.95%) on December 31, 2023.
- During the last 3 years, ORGO annual SGA has risen by +$65.56 million (+32.11%).
- ORGO annual SGA is now -4.95% below its all-time high of $283.81 million, reached on December 31, 2022.
Performance
ORGO SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$71.80 M
-$4.75 M-6.20%
September 30, 2024
Summary
- As of February 8, 2025, ORGO quarterly SGA is $71.80 million, with the most recent change of -$4.75 million (-6.20%) on September 30, 2024.
- Over the past year, ORGO quarterly SGA has increased by +$10.41 million (+16.97%).
- ORGO quarterly SGA is now -9.50% below its all-time high of $79.33 million, reached on September 30, 2022.
Performance
ORGO Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
-$191.94 M
-$7.38 M-4.00%
September 30, 2024
Summary
- As of February 8, 2025, ORGO TTM SGA is -$191.94 million, with the most recent change of -$7.38 million (-4.00%) on September 30, 2024.
- Over the past year, ORGO TTM SGA has dropped by -$461.69 million (-171.15%).
- ORGO TTM SGA is now -465771.36% below its all-time high of -$41.20 thousand.
Performance
ORGO TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
ORGO Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -5.0% | +17.0% | -171.2% |
| 3 y3 years | +32.1% | +17.0% | -171.2% |
| 5 y5 years | +66.5% | +45.1% | -191.6% |
ORGO Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -5.0% | +7.8% | -9.5% | +17.0% | -14.2% | +55.7% |
| 5 y | 5-year | -5.0% | +34.8% | -9.5% | +54.4% | -14.2% | +73.4% |
| alltime | all time | -5.0% | +190.0% | -9.5% | +90.3% | <-9999.0% | +73.4% |
Organogenesis Holdings Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $71.80 M(-6.2%) | $282.04 M(+2.8%) |
| Jun 2024 | - | $76.54 M(+5.8%) | $274.46 M(+2.3%) |
| Mar 2024 | - | $72.32 M(+17.8%) | $268.24 M(-0.6%) |
| Dec 2023 | $269.75 M(-5.0%) | $61.38 M(-4.4%) | $269.75 M(-2.5%) |
| Sep 2023 | - | $64.22 M(-8.7%) | $276.67 M(-5.2%) |
| Jun 2023 | - | $70.32 M(-4.8%) | $291.77 M(-0.8%) |
| Mar 2023 | - | $73.83 M(+8.1%) | $294.06 M(+3.6%) |
| Dec 2022 | $283.81 M(+13.4%) | $68.29 M(-13.9%) | $283.81 M(+0.4%) |
| Sep 2022 | - | $79.33 M(+9.3%) | $282.76 M(+6.4%) |
| Jun 2022 | - | $72.61 M(+14.2%) | $265.81 M(+4.0%) |
| Mar 2022 | - | $63.58 M(-5.5%) | $255.55 M(+2.1%) |
| Dec 2021 | $250.20 M | $67.25 M(+7.8%) | $250.20 M(+5.9%) |
| Sep 2021 | - | $62.37 M(+0.0%) | $236.35 M(+4.9%) |
| Jun 2021 | - | $62.35 M(+7.1%) | $225.30 M(+7.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2021 | - | $58.23 M(+9.1%) | $209.46 M(+2.8%) |
| Dec 2020 | $204.19 M(+2.1%) | $53.40 M(+4.0%) | $203.84 M(+0.3%) |
| Sep 2020 | - | $51.33 M(+10.4%) | $203.20 M(+0.9%) |
| Jun 2020 | - | $46.50 M(-11.6%) | $201.35 M(-1.2%) |
| Mar 2020 | - | $52.61 M(-0.3%) | $203.81 M(+1.9%) |
| Dec 2019 | $200.09 M(+23.5%) | $52.76 M(+6.6%) | $200.09 M(+2.7%) |
| Sep 2019 | - | $49.48 M(+1.1%) | $194.80 M(+5.9%) |
| Jun 2019 | - | $48.96 M(+0.1%) | $183.91 M(+6.5%) |
| Mar 2019 | - | $48.89 M(+3.0%) | $172.69 M(+6.6%) |
| Dec 2018 | $161.96 M(+21.1%) | $47.48 M(+23.1%) | $161.96 M(+41.5%) |
| Sep 2018 | - | $38.58 M(+2.2%) | $114.48 M(+50.8%) |
| Jun 2018 | - | $37.73 M(-1.1%) | $75.90 M(+98.9%) |
| Mar 2018 | - | $38.16 M | $38.16 M |
| Dec 2017 | $133.72 M(+43.7%) | - | - |
| Dec 2016 | $93.03 M | - | - |
FAQ
- What is Organogenesis Holdings annual SGA?
- What is the all time high annual SGA for Organogenesis Holdings?
- What is Organogenesis Holdings annual SGA year-on-year change?
- What is Organogenesis Holdings quarterly SGA?
- What is the all time high quarterly SGA for Organogenesis Holdings?
- What is Organogenesis Holdings quarterly SGA year-on-year change?
- What is Organogenesis Holdings TTM SGA?
- What is the all time high TTM SGA for Organogenesis Holdings?
- What is Organogenesis Holdings TTM SGA year-on-year change?
What is Organogenesis Holdings annual SGA?
The current annual SGA of ORGO is $269.75 M
What is the all time high annual SGA for Organogenesis Holdings?
Organogenesis Holdings all-time high annual SGA is $283.81 M
What is Organogenesis Holdings annual SGA year-on-year change?
Over the past year, ORGO annual SGA has changed by -$14.05 M (-4.95%)
What is Organogenesis Holdings quarterly SGA?
The current quarterly SGA of ORGO is $71.80 M
What is the all time high quarterly SGA for Organogenesis Holdings?
Organogenesis Holdings all-time high quarterly SGA is $79.33 M
What is Organogenesis Holdings quarterly SGA year-on-year change?
Over the past year, ORGO quarterly SGA has changed by +$10.41 M (+16.97%)
What is Organogenesis Holdings TTM SGA?
The current TTM SGA of ORGO is -$191.94 M
What is the all time high TTM SGA for Organogenesis Holdings?
Organogenesis Holdings all-time high TTM SGA is -$41.20 K
What is Organogenesis Holdings TTM SGA year-on-year change?
Over the past year, ORGO TTM SGA has changed by -$461.69 M (-171.15%)